![Michelle Seltenrich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Seltenrich
Corporate Officer/Principal chez
RAKOVINA THERAPEUTICS INC.
Fortune : 5 908 $ au 31/08/2026
Profil
Michelle Seltenrich is currently Vice President-Operations at Rakovina Therapeutics, Inc., a position starting in 2026.
Formerly, Ms. Seltenrich was Vice President-Operations at Sirona Biochem Corp.
from 2014 to 2023 and Manager-Business Development at Forbes Medi-Tech, Inc. from 2004 to 2008.
Education includes an undergraduate degree from the University of British Columbia in 1996 and an MBA from Simon Fraser University in 2008.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/09/2026 | 43 438 ( 0,21 % ) | 5 908 $ | 31/08/2026 |
Postes actifs de Michelle Seltenrich
| Sociétés | Poste | Début |
|---|---|---|
| RAKOVINA THERAPEUTICS INC. | Corporate Officer/Principal | 01/10/2024 |
Anciens postes connus de Michelle Seltenrich
| Sociétés | Poste | Fin |
|---|---|---|
| SIRONA BIOCHEM CORP. | Directeur des opérations | 01/08/2023 |
Forbes Medi-Tech, Inc.
 Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets nutraceutical products | Corporate Officer/Principal | 01/05/2008 |
Formation de Michelle Seltenrich
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Forbes Medi-Tech, Inc.
Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets nutraceutical products | Health Technology |
Sirona Biochem Corp.
 Sirona Biochem Corp. Pharmaceuticals: MajorHealth Technology Develops cosmetic and pharmaceutical active ingredients | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simon Fraser University
 Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rakovina Therapeutics, Inc.
 Rakovina Therapeutics, Inc. Financial ConglomeratesFinance Develops oncology therapeutics | Finance |
